Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been sued in the US District Court for the District of New...
Archive for category: Intellectual Property Rights
Orexigen and Takeda Feud Over Cost of a Controversial Diet Drug Trial – Courtesy (Pharmalot)
Pharma Live, , Intellectual Property Rights, 0The controversy surrounding Orexigen Therapeutics OREX -0.20% and its release of interim study data for its Contrave diet pill...
Activists Urge Lawmakers to Prioritize Patients Over Patents – Courtesy(Jakarta Globe)
Pharma Live, , Intellectual Property Rights, 0Jakarta. Public health activists have called on the government to review a number of key points included in a revised...
Should Vietnam introduce patent term extension? – Coutesy (Lexology)
Pharma Live, , Intellectual Property Rights, 0Patents play a key role in encouraging the development of pharmaceutical products. It can take several hundred million dollars...
Amarantus Bioscience Receives Notice Of Allowance For U.S. Patent Application Covering Proprietary Compositions Of Matter And Methods Of Use for manufacture -Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0SAN FRANCISCO and GENEVA, May 5, 2015 (GLOBE NEWSWIRE) — Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on...
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
GW Pharmaceuticals Announces Us Patent Allowance For Use Of Cannabidivarin (CBDV) In Treating Epilepsy – Courtesy( Biospace)
Pharma Live, , Intellectual Property Rights, 0GW Pharmaceuticals plc (AIM:GWP) (Nasdaq:GWPH) (“GW”) announced that the United States Patent and Trademark Office (USPTO) has issued a...
Pluristem Therapeutics Inc Granted European Patent For Use Of Cells To Help Treat Damaged Bone Marrow – Courtesy (Biospace)
Pharma Live, , Intellectual Property Rights, 0Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced that it has been issued...
Erytech Strengthens Its Intellectual Property Position In The U.S. – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0ERYTECH (Paris:ERYP) (ADR:EYRYY), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications...
Gene Associated with ALS identified ! – Courtesy(Patent Docs)
Pharma Live, , Intellectual Property Rights, 0One of the promises of the Human Genome Project was that knowledge of the entirety of the human genetic...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)